John M. Schallenkamp

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Charles E. Geyer, Judy E. Garber, Richard D. Gelber et al. · Annals of Oncology · 2022 · 404 citations · Full text

Breast Oncology, Overall Survival, Medicine +7

Prostate position relative to pelvic bony anatomy based on intraprostatic gold markers and electronic portal imaging

John M. Schallenkamp, Michael Herman, Jon J. Kruse et al. · International Journal of Radiation Oncology*Biology*Physics · 2005 · 241 citations

Electronic Portal Imaging, Urology, Imaging Anatomy +9

Quality of Life Analysis of a Radiation Dose–Escalation Study of Patients With Non–Small-Cell Lung Cancer

Benjamin Movsas, Chen Hu, Jeffrey A. Sloan et al. · JAMA Oncology · 2015 · 177 citations · Full text

Incidence of radiation pneumonitis after thoracic irradiation: Dose-volume correlates

John M. Schallenkamp, Robert C. Miller, Debra H. Brinkmann et al. · International Journal of Radiation Oncology*Biology*Physics · 2007 · 162 citations

Pneumothorax, Radiation Exposure, Radiation Dose +6

Survivorship care plans: Is there buy‐in from community oncology providers?

Talya Salz, Mary S. McCabe, Erin E. Onstad et al. · Cancer · 2013 · 69 citations · Full text